HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marinos Dalakas Selected Research

Dermatomyositis (Dermatopolymyositis)

7/2008IVIg in other autoimmune neurological disorders: current status and future prospects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marinos Dalakas Research Topics

Disease

3Multiple Sclerosis
04/2022 - 01/2020
2Disease Progression
04/2022 - 04/2012
2Myositis (Idiopathic Inflammatory Myopathies)
04/2014 - 07/2008
1Autoimmune Diseases (Autoimmune Disease)
04/2012
1Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
06/2011
1Alzheimer Disease (Alzheimer's Disease)
07/2008
1Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis)
07/2008
1Deglutition Disorders (Dysphagia)
07/2008
1Inclusion Body Myositis
07/2008
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2008
1Pain (Aches)
07/2008
1Fibrosis (Cirrhosis)
07/2008
1Dermatomyositis (Dermatopolymyositis)
07/2008
1Sleep Wake Disorders
07/2008
1Nervous System Diseases (Neurological Disorders)
07/2008
1Postpoliomyelitis Syndrome (Post-Polio Syndrome)
07/2008
1Stiff-Person Syndrome (Stiff Man Syndrome)
07/2008
1Demyelinating Diseases (Demyelinating Disease)
02/2007
1Polyneuropathies (Polyneuropathy)
02/2007
1Muscular Diseases (Myopathy)
01/2006
1Rhabdomyosarcoma
01/2006

Drug/Important Bio-Agent (IBA)

2HLA-DRB1 Chains (HLA DRB1)IBA
04/2022 - 01/2020
2AntibodiesIBA
07/2008 - 02/2007
1HLA-DRB1*04 antigenIBA
04/2022
1Fingolimod Hydrochloride (FTY720)FDA Link
04/2022
1Natalizumab (Tysabri)FDA Link
01/2022
12-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
04/2014
1Myelin-Associated GlycoproteinIBA
04/2012
1Rituximab (Mabthera)FDA Link
04/2012
1Monoclonal AntibodiesIBA
04/2012
1AntigensIBA
04/2012
1AutoantibodiesIBA
04/2012
1Immunoglobulin G (IgG)IBA
04/2012
1Immunoglobulin M (IgM)IBA
04/2012
1Biomarkers (Surrogate Marker)IBA
06/2011
1Intravenous Immunoglobulins (IVIG)FDA Link
07/2008
1sulfate-3-glucuronyl paraglobosideIBA
02/2007
1Glycoproteins (Glycoprotein)IBA
02/2007
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2006
1Messenger RNA (mRNA)IBA
01/2006
1Interleukin-8 (Interleukin 8)IBA
01/2006

Therapy/Procedure

5Therapeutics
04/2022 - 07/2008